This site is for Healthcare Professionals only | Consumer Site
Visit for additional allergy management information and products.

RHINOCORT® Allergy Spray improves quality of life

In adult perennial allergic rhinitis (PAR) patients, RHINOCORT® Allergy Spray significantly improved quality of life (QoL) compared with placebo*1

RHINOCORT® vs. placebo RQLQ Scores RHINOCORT® vs. placebo RQLQ Scores RHINOCORT® vs. placebo RQLQ Scores

The Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) is a validated measurement of overall QoL. The study used the 28-item RQLQ, which measured: sleep, non–hay fever symptoms, practical problems, nasal symptoms, eye symptom, emotions, and overall function.

* Multicenter, randomized, double-blind, placebo-controlled study including 374 adult PAR patients. Primary study endpoint measured changes in overall NIS score from baseline. RQLQ score was a secondary endpoint. Data reflected are for 128 μg once-daily (n=97) vs placebo (n=93).


  1. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.